Contrave
Designed to target appetite regulation, this product is utilized to support weight control and alleviate behaviours associated with overeating.
Strengths: 8/90mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Mysimba; Bupropion + Naltrexone Tablets
- Therapeutic class
Weight Loss Agent
- Pharmacological class
Antiobesity Agent
- Precautions and warnings
monitor blood pressure
- Minor side effects
nausea; constipation; headache
- Moderate side effects
dizziness; insomnia
- Serious side effects
seizure — requires immediate medical attention
- Dosage forms
Prolonged-release tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Orexigen Therapeutics
- Onset Time
1–2 weeks
- Duration
24 hours
- Storage instructions
Store at room temperature.
- Drug interactions
opioids; alcohol
- Age restrictions
For adults only.
- Pregnancy and breastfeeding
Pregnancy: Do not use. Breastfeeding: Do not use.
Contraindications
hypersensitivity to components; uncontrolled hypertension; seizure disorders; eating disorders
Patient summary
Designed to target appetite regulation, this product is utilized to support weight control and alleviate behaviours associated with overeating.
Mechanism of action
This combination medication acts by modulating the reward system and appetite-regulating centres in the brain to reduce food cravings and control caloric intake.
Contrave
Designed to target appetite regulation, this product is utilized to support weight control and alleviate behaviours associated with overeating.
Editorial Notes
- Active ingredient(s): Bupropion, Naltrexone
- Listed indication(s): Obesity
Available option
- 60 tablets - 8/90 mg1239-8-90-mg-14804